+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Cryo-EM Structure of the BRAF K601E monomer | |||||||||
![]() | ||||||||||
![]() |
| |||||||||
![]() | BRAF Kinase Oncogenic Mutant Monomer / TRANSFERASE-INHIBITOR complex | |||||||||
Function / homology | ![]() synaptic target recognition / Golgi reassembly / CD4-positive, alpha-beta T cell differentiation / positive regulation of axon regeneration / NOTCH4 Activation and Transmission of Signal to the Nucleus / CD4-positive or CD8-positive, alpha-beta T cell lineage commitment / establishment of Golgi localization / negative regulation of synaptic vesicle exocytosis / Signalling to p38 via RIT and RIN / respiratory system process ...synaptic target recognition / Golgi reassembly / CD4-positive, alpha-beta T cell differentiation / positive regulation of axon regeneration / NOTCH4 Activation and Transmission of Signal to the Nucleus / CD4-positive or CD8-positive, alpha-beta T cell lineage commitment / establishment of Golgi localization / negative regulation of synaptic vesicle exocytosis / Signalling to p38 via RIT and RIN / respiratory system process / head morphogenesis / ARMS-mediated activation / tube formation / myeloid progenitor cell differentiation / regulation of synapse maturation / endothelial cell apoptotic process / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / Rap1 signalling / positive regulation of D-glucose transmembrane transport / negative regulation of fibroblast migration / establishment of protein localization to membrane / positive regulation of axonogenesis / negative regulation of protein localization to nucleus / regulation of T cell differentiation / Negative feedback regulation of MAPK pathway / KSRP (KHSRP) binds and destabilizes mRNA / mitogen-activated protein kinase kinase binding / GP1b-IX-V activation signalling / Frs2-mediated activation / stress fiber assembly / face development / MAP kinase kinase activity / synaptic vesicle exocytosis / thyroid gland development / Regulation of localization of FOXO transcription factors / Interleukin-3, Interleukin-5 and GM-CSF signaling / somatic stem cell population maintenance / phosphoserine residue binding / positive regulation of peptidyl-serine phosphorylation / Activation of BAD and translocation to mitochondria / MAP kinase kinase kinase activity / postsynaptic modulation of chemical synaptic transmission / protein targeting / negative regulation of endothelial cell apoptotic process / regulation of ERK1 and ERK2 cascade / Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex / SARS-CoV-2 targets host intracellular signalling and regulatory pathways / response to cAMP / cellular response to glucose starvation / SARS-CoV-1 targets host intracellular signalling and regulatory pathways / RHO GTPases activate PKNs / positive regulation of stress fiber assembly / negative regulation of TORC1 signaling / ERK1 and ERK2 cascade / positive regulation of substrate adhesion-dependent cell spreading / Transcriptional and post-translational regulation of MITF-M expression and activity / substrate adhesion-dependent cell spreading / protein sequestering activity / cellular response to calcium ion / negative regulation of innate immune response / hippocampal mossy fiber to CA3 synapse / thymus development / animal organ morphogenesis / Translocation of SLC2A4 (GLUT4) to the plasma membrane / TP53 Regulates Metabolic Genes / Deactivation of the beta-catenin transactivating complex / lung development / RAF activation / histone H4S1 kinase activity / histone H2BS14 kinase activity / histone H2AS121 kinase activity / histone H3S57 kinase activity / eukaryotic translation initiation factor 2alpha kinase activity / histone H3S28 kinase activity / histone H2AS1 kinase activity / histone H3T6 kinase activity / Negative regulation of NOTCH4 signaling / cellular response to nerve growth factor stimulus / ribosomal protein S6 kinase activity / Spry regulation of FGF signaling / histone H2AT120 kinase activity / histone H2BS36 kinase activity / Rho-dependent protein serine/threonine kinase activity / histone H3S10 kinase activity / Signaling by high-kinase activity BRAF mutants / AMP-activated protein kinase activity / 3-phosphoinositide-dependent protein kinase activity / histone H3T11 kinase activity / histone H3T3 kinase activity / histone H3T45 kinase activity / MAP2K and MAPK activation / DNA-dependent protein kinase activity / histone H2AXS139 kinase activity / visual learning / regulation of protein stability / response to peptide hormone / centriolar satellite / long-term synaptic potentiation / epidermal growth factor receptor signaling pathway Similarity search - Function | |||||||||
Biological species | ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 5.86 Å | |||||||||
![]() | Lavoie H / Lajoie D / Jin T / Decossas M / Maisonneuve P / Therrien M | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: BRAF oncogenic mutants evade autoinhibition through a common mechanism. Authors: Hugo Lavoie / Ting Jin / Driss Lajoie / Marion Decossas / Patrick Gendron / Bing Wang / Frantisek Filandr / Malha Sahmi / Chang Hwa Jo / Sandra Weber / Geneviève Arseneault / Sasmita ...Authors: Hugo Lavoie / Ting Jin / Driss Lajoie / Marion Decossas / Patrick Gendron / Bing Wang / Frantisek Filandr / Malha Sahmi / Chang Hwa Jo / Sandra Weber / Geneviève Arseneault / Sasmita Tripathy / Pierre Beaulieu / Doris A Schuetz / David C Schriemer / Anne Marinier / William J Rice / Pierre Maisonneuve / Marc Therrien / ![]() ![]() ![]() Abstract: Uncontrolled activation of the rat sarcoma (RAS)-extracellular signal-regulated kinase (ERK) pathway drives tumor growth, often because of oncogenic BRAF mutations. BRAF regulation, involving ...Uncontrolled activation of the rat sarcoma (RAS)-extracellular signal-regulated kinase (ERK) pathway drives tumor growth, often because of oncogenic BRAF mutations. BRAF regulation, involving monomeric autoinhibition and activation by dimerization, has been intensely scrutinized, but mechanisms enabling oncogenic mutants to evade regulation remain unclear. By using cryo-electron microscopy, we solved the three-dimensional structures of the three oncogenic BRAF mutant classes, including the common V600E variant. These mutations disrupted wild-type BRAF's autoinhibited state, mediated by interactions between the cysteine-rich domain and kinase domain, thereby shifting the kinase domain into a preactivated conformation. This structural change likely results from helix αC displacement. PLX8394, a BRAF inhibitor that stabilizes helix αC in an inactive conformation, restored the autoinhibited conformation of oncogenic BRAF, explaining the properties of this class of compounds. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 59.7 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 20.4 KB 20.4 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 11.8 KB | Display | ![]() |
Images | ![]() | 70.8 KB | ||
Filedesc metadata | ![]() | 7 KB | ||
Others | ![]() ![]() | 59.5 MB 59.5 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 864.9 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 864.5 KB | Display | |
Data in XML | ![]() | 16.1 KB | Display | |
Data in CIF | ![]() | 21.3 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 8vyvMC ![]() 8vyoC ![]() 8vypC ![]() 8vyqC ![]() 8vyrC ![]() 8vysC ![]() 8vyuC ![]() 8vywC M: atomic model generated by this map C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.825 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: #2
File | emd_43679_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #1
File | emd_43679_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : BRAF K601E - 14-3-3 complex
Entire | Name: BRAF K601E - 14-3-3 complex |
---|---|
Components |
|
-Supramolecule #1: BRAF K601E - 14-3-3 complex
Supramolecule | Name: BRAF K601E - 14-3-3 complex / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all Details: BRAF K601E - 14-3-3 complex purified by FLAG affinity purification followed by TEV elution from FreeStyle 293-F cells |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 141 KDa |
-Macromolecule #1: 14-3-3 protein zeta/delta
Macromolecule | Name: 14-3-3 protein zeta/delta / type: protein_or_peptide / ID: 1 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 27.777092 KDa |
Sequence | String: MDKNELVQKA KLAEQAERYD DMAACMKSVT EQGAELSNEE RNLLSVAYKN VVGARRSSWR VVSSIEQKTE GAEKKQQMAR EYREKIETE LRDICNDVLS LLEKFLIPNA SQAESKVFYL KMKGDYYRYL AEVAAGDDKK GIVDQSQQAY QEAFEISKKE M QPTHPIRL ...String: MDKNELVQKA KLAEQAERYD DMAACMKSVT EQGAELSNEE RNLLSVAYKN VVGARRSSWR VVSSIEQKTE GAEKKQQMAR EYREKIETE LRDICNDVLS LLEKFLIPNA SQAESKVFYL KMKGDYYRYL AEVAAGDDKK GIVDQSQQAY QEAFEISKKE M QPTHPIRL GLALNFSVFY YEILNSPEKA CSLAKTAFDE AIAELDTLSE ESYKDSTLIM QLLRDNLTLW TSDTQGDEAE AG EGGEN UniProtKB: 14-3-3 protein zeta/delta |
-Macromolecule #2: Serine/threonine-protein kinase B-raf
Macromolecule | Name: Serine/threonine-protein kinase B-raf / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO / EC number: non-specific serine/threonine protein kinase |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 84.75468 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: GMAALSGGGG GGAEPGQALF NGDMEPEAGA GAGAAASSAA DPAIPEEVWN IKQMIKLTQE HIEALLDKFG GEHNPPSIYL EAYEEYTSK LDALQQREQQ LLESLGNGTD FSVSSSASMD TVTSSSSSSL SVLPSSLSVF QNPTDVARSN PKSPQKPIVR V FLPNKQRT ...String: GMAALSGGGG GGAEPGQALF NGDMEPEAGA GAGAAASSAA DPAIPEEVWN IKQMIKLTQE HIEALLDKFG GEHNPPSIYL EAYEEYTSK LDALQQREQQ LLESLGNGTD FSVSSSASMD TVTSSSSSSL SVLPSSLSVF QNPTDVARSN PKSPQKPIVR V FLPNKQRT VVPARCGVTV RDSLKKALMM RGLIPECCAV YRIQDGEKKP IGWDTDISWL TGEELHVEVL ENVPLTTHNF VR KTFFTLA FCDFCRKLLF QGFRCQTCGY KFHQRCSTEV PLMCVNYDQL DLLFVSKFFE HHPIPQEEAS LAETALTSGS SPS APASDS IGPQILTSPS PSKSIPIPQP FRPADEDHRN QFGQRDRSS(SEP) APNVHINTIE PVNIDDLIRD QGFRGDGGST TGLSATPPA SLPGSLTNVK ALQKSPGPQR ERKSSSSSED RNRMKTLGRR DSSDDWEIPD GQITVGQRIG SGSFGTVYKG K WHGDVAVK MLNVTAPTPQ QLQAFKNEVG VLRKTRHVNI LLFMGYSTKP QLAIVTQWCE GSSLYHHLHI IETKFEMIKL ID IARQTAQ GMDYLHAKSI IHRDLKSNNI FLHEDLTVKI GDFGLATVES RWSGSHQFEQ LSGSILWMAP EVIRMQDKNP YSF QSDVYA FGIVLYELMT GQLPYSNINN RDQIIFMVGR GYLSPDLSKV RSNCPKAMKR LMAECLKKKR DERPLFPQIL ASIE LLARS LPKIHRSA(SEP)E PSLNRAGFQT EDFSLYACAS PKTPIQAGGY GAFPVH UniProtKB: Serine/threonine-protein kinase B-raf |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 1 mg/mL | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 7.5 Component:
| ||||||||||||||||||
Vitrification | Cryogen name: ETHANE / Details: Chameleon system (SPT Labtech). |
-
Electron microscopy
Microscope | TFS KRIOS |
---|---|
Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Average electron dose: 51.55 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 4.5 µm / Nominal defocus min: 1.4000000000000001 µm |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |